{"id":24478,"date":"2025-05-23T15:06:32","date_gmt":"2025-05-23T13:06:32","guid":{"rendered":"https:\/\/lombardialifesciences.it\/?p=24478"},"modified":"2025-05-23T15:06:32","modified_gmt":"2025-05-23T13:06:32","slug":"salute-aperti-ufficialmente-due-nuovi-bandi-di-horizon-europe","status":"publish","type":"post","link":"https:\/\/lombardialifesciences.it\/en\/salute-aperti-ufficialmente-due-nuovi-bandi-di-horizon-europe\/","title":{"rendered":"Salute: aperti ufficialmente due nuovi bandi di Horizon Europe"},"content":{"rendered":"<p>Ufficialmente\u00a0<strong>aperti due nuovi bandi del cluster salute di Horizon Europe<\/strong>, pubblicati nel nuovo\u00a0<strong>Work Programme 2025<\/strong>.<\/p>\n<p>Le due call (HORIZON-HLTH-2025-01 e HORIZON-HLTH-2025-03-two-stage) contengono complessivamente\u00a0<strong>18 topic per un budget pari a 700 milioni di euro<\/strong>. Di seguito i dettagli dei due bandi:<\/p>\n<h2><strong>HORIZON-HLTH-2025-01: Cluster 1 &#8211; Health (Single stage &#8211; 2025)<\/strong><\/h2>\n<p>Il bando ha un budget complessivo pari a\u00a0<strong>486 milioni di euro<\/strong>\u00a0e contiene i seguenti\u00a0<strong>13 topic<\/strong>:<\/p>\n<ul>\n<li>HORIZON-HLTH-2025-01-DISEASE-01: Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections<\/li>\n<li>HORIZON-HLTH-2025-01-DISEASE-03: Development of antibodies and antibodyderived proteins for the prevention and treatment of infectious diseases with epidemic potential<\/li>\n<li>HORIZON-HLTH-2025-01-DISEASE-04: Leveraging artificial intelligence for pandemic preparedness and response<\/li>\n<li>HORIZON-HLTH-2025-01-DISEASE-05:\u00a0Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)<\/li>\n<li>HORIZON-HLTH-2025-01-DISEASE-06: Implementation research addressing strategies to strengthen health systems for equitable highquality care and health outcomes in the context of non-communicable diseases (GACD)<\/li>\n<li>HORIZON-HLTH-2025-01-DISEASE-07: Tackling high-burden for patients and underresearched medical conditions<\/li>\n<li>HORIZON-HLTH-2025-01-CARE-01: End user-driven application of Generative Artificial Intelligence models in healthcare (GenAI4EU)<\/li>\n<li>HORIZON-HLTH-2025-01-TOOL-01: Enhancing cell therapies with genomic techniques<\/li>\n<li>HORIZON-HLTH-2025-01-TOOL-02: Advancing cell secretome-based therapies<\/li>\n<li>HORIZON-HLTH-2025-01-TOOL-03: Leveraging multimodal data to advance Generative Artificial Intelligence applicability in biomedical research (GenAI4EU)<\/li>\n<li>HORIZON-HLTH-2025-01-TOOL-05: Boosting the translation of biotech research into innovative health therapies<\/li>\n<li>HORIZON-HLTH-2025-01-IND-01: Optimising the manufacturing of Advanced Therapy Medicinal Products (ATMPs)<\/li>\n<li>HORIZON-HLTH-2025-01-IND-02: Digitalisation of conformity assessment procedures of medical devices and in vitro\u00a0diagnostic medical devices<\/li>\n<\/ul>\n<p>I topic si aprono tutti il 22 maggio 2025 e si chiudono il\u00a0<strong>16 settembre 2025<\/strong>.<\/p>\n<h2><strong>HORIZON-HLTH-2025-03-two-stage: Cluster 1 &#8211; Health (Two stage &#8211; 2025)<\/strong><\/h2>\n<p>Il bando ha un budget complessivo pari a\u00a0<strong>210 milioni di euro<\/strong>\u00a0e contiene i seguenti\u00a0<strong>5 topic<\/strong>:<\/p>\n<ul>\n<li>HORIZON-HLTH-2025-03-STAYHLTH-01-two-stage: Improving the quality of life of persons with intellectual disabilities and their families<\/li>\n<li>HORIZON-HLTH-2025-03-ENVHLTH-01-two-stage: The impact of pollution on the development and progression of brain diseases and disorders<\/li>\n<li>HORIZON-HLTH-2025-03-ENVHLTH-02-two-stage: Advancing knowledge on the impacts of micro- and nanoplastics on human health<\/li>\n<li>HORIZON-HLTH-2025-03-DISEASE-02-two-stage: Advancing innovative interventions for mental, behavioural and neurodevelopmental disorders<\/li>\n<li>HORIZON-HLTH-2025-03-IND-03-twostage: Facilitating the conduct of multinational clinical studies of orphan devices and\/or of highly innovative (\u201cbreakthrough\u201d) devices<\/li>\n<\/ul>\n<p>Tutti i topic prevedono una\u00a0<strong>valutazione a due step<\/strong>, con la chiusura\u00a0<em>first stage<\/em>\u00a0prevista per il\u00a0<strong>16 settembre 2025<\/strong>\u00a0mentre la valutazione\u00a0<em>second stage<\/em>\u00a0(solo per le proposte che superano il primo step) \u00e8 prevista per il\u00a0<strong>16 aprile 2026<\/strong>.<\/p>\n<p>&nbsp;<\/p>\n<p>Clicca qui per maggiori informazioni su\u00a0<a class=\"external-link\" title=\"\" href=\"https:\/\/ec.europa.eu\/info\/funding-tenders\/opportunities\/portal\/screen\/opportunities\/calls-for-proposals?callIdentifier=HORIZON-HLTH-2025-01&amp;isExactMatch=true&amp;status=31094501,31094502,31094503&amp;order=DESC&amp;pageNumber=1&amp;pageSize=50&amp;sortBy=startDate\" target=\"_blank\" rel=\"noopener\">HORIZON-HLTH-2025-01<\/a>\u00a0e\u00a0<a class=\"external-link\" title=\"\" href=\"https:\/\/ec.europa.eu\/info\/funding-tenders\/opportunities\/portal\/screen\/opportunities\/calls-for-proposals?callIdentifier=HORIZON-HLTH-2025-03-two-stage&amp;isExactMatch=true&amp;status=31094501,31094502,31094503&amp;order=DESC&amp;pageNumber=1&amp;pageSize=50&amp;sortBy=startDate\" target=\"_blank\" rel=\"noopener\">HORIZON-HLTH-2025-03<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ufficialmente\u00a0aperti due nuovi bandi del cluster salute di Horizon Europe, pubblicati nel nuovo\u00a0Wo&#8230;<\/p>\n","protected":false},"author":4,"featured_media":11483,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[2,44],"tags":[],"class_list":["post-24478","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","category-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/posts\/24478","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/comments?post=24478"}],"version-history":[{"count":1,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/posts\/24478\/revisions"}],"predecessor-version":[{"id":24479,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/posts\/24478\/revisions\/24479"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/media\/11483"}],"wp:attachment":[{"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/media?parent=24478"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/categories?post=24478"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/tags?post=24478"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}